financial statements
The full income statement, balance sheet, and cash-flow statement for Abbott Laboratories (ABT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 44.3B YoY+5.7% | 42.0B YoY+4.6% | 40.1B YoY-8.1% | 43.7B YoY+1.3% | 43.1B YoY+24.5% | |
| Cost of revenue | 19.3B YoY+3.3% | 18.7B YoY+4.1% | 18.0B YoY-6.1% | 19.1B YoY+3.3% | 18.5B YoY+23.6% | |
| Research & development | 2.94B YoY+3.4% | 2.84B YoY+3.8% | 2.74B YoY-5.1% | 2.89B YoY+5.3% | 2.74B YoY+13.3% | |
| Selling, general & administrative | 12.3B YoY+5.4% | 11.7B YoY+6.8% | 10.9B YoY-2.7% | 11.2B YoY-0.7% | 11.3B YoY+16.8% | |
| Amortization of intangibles | 1.68B YoY-10.4% | 1.88B YoY-4.5% | 1.97B YoY-2.3% | 2.01B YoY-1.7% | 2.05B YoY-4.0% | |
| Provision for credit losses | 75.0M YoY+23.0% | 61.0M YoY+134.6% | 26.0M YoY+333.3% | 6.00M YoY-88.2% | 51.0M YoY-42.0% | |
| Operating income | 8.05B YoY+18.0% | 6.83B YoY+5.4% | 6.48B YoY-22.5% | 8.36B YoY-0.7% | 8.43B YoY+57.3% | |
| Interest expense | 493M YoY-11.8% | 559M YoY-12.2% | 637M YoY+14.2% | 558M YoY+4.7% | 533M YoY-2.4% | |
| Interest & investment income | 308M YoY-10.5% | 344M YoY-10.6% | 385M YoY+110.4% | 183M YoY+325.6% | 43.0M YoY-6.5% | |
| Other non-operating income | 548M YoY+45.7% | 376M YoY-21.5% | 479M YoY+49.2% | 321M YoY+15.9% | 277M YoY+168.9% | |
| Pre-tax income | 8.47B YoY+20.7% | 7.01B YoY+5.2% | 6.66B YoY-19.8% | 8.31B YoY+1.2% | 8.21B YoY+65.3% | |
| Income tax | 1.94B YoY+130.4% | -6.39B YoY-779.0% | 941M YoY-31.5% | 1.37B YoY+20.4% | 1.14B YoY+129.4% | |
6.52B YoY-51.3% | 13.4B YoY+134.2% | 5.72B YoY-17.5% | 6.93B YoY-2.0% | 7.07B YoY+57.3% | ||
$3.72 YoY-51.3% | $7.64 YoY+134.4% | $3.26 YoY-16.6% | $3.91 YoY-0.8% | $3.94 YoY+57.6% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
26.0B YoY+9.9% | 23.7B YoY+4.3% | 22.7B YoY-10.1% | 25.2B YoY+4.1% | 24.2B YoY+18.6% | ||
86.7B YoY+6.5% | 81.4B YoY+11.2% | 73.2B YoY-1.6% | 74.4B YoY-1.0% | 75.2B YoY+3.6% | ||
16.5B YoY+16.5% | 14.2B YoY+2.3% | 13.8B YoY-10.6% | 15.5B YoY+18.2% | 13.1B YoY+10.1% | ||
| Long-term debt | 9.90B YoY-21.6% | 12.6B YoY-7.2% | 13.6B YoY-6.4% | 14.5B YoY-16.0% | 17.3B YoY-6.6% | |
| Non-current lease liability | 931M YoY+3.9% | 896M YoY-5.6% | 949M YoY+0.6% | 943M YoY-1.4% | 956M YoY+6.0% | |
| Deferred tax liabilities | 860M YoY+0.0% | 860M YoY+0.0% | 860M YoY+0.0% | 860M YoY+0.0% | 860M YoY+0.0% | |
| Other non-current liabilities | 2.54B YoY-1.9% | 2.59B YoY-25.4% | 3.47B YoY-8.9% | 3.80B YoY+3.2% | 3.69B YoY-59.2% | |
52.1B YoY+9.4% | 47.7B YoY+23.5% | 38.6B YoY+5.2% | 36.7B YoY+2.5% | 35.8B YoY+9.2% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
9.57B YoY+11.8% | 8.56B YoY+17.9% | 7.26B YoY-24.2% | 9.58B YoY-9.0% | 10.5B YoY+33.3% | ||
-2.42B YoY-3.6% | -2.34B YoY+25.4% | -3.13B YoY-80.1% | -1.74B YoY+13.3% | -2.01B YoY+9.3% | ||
-6.31B YoY-16.7% | -5.40B YoY+23.8% | -7.09B YoY+7.1% | -7.64B YoY-39.0% | -5.49B YoY-97.7% | ||
| Net change in cash | 906M YoY+25.8% | 720M YoY+124.1% | -2.99B YoY-3697.6% | 83.0M YoY-97.2% | 2.96B YoY-0.6% | |
| Interest paid | 545M YoY-9.8% | 604M YoY-8.8% | 662M YoY+17.6% | 563M YoY+3.5% | 544M YoY-0.9% | |
| Income taxes paid | 1.93B YoY+12.2% | 1.72B YoY+16.8% | 1.48B YoY-20.9% | 1.86B YoY-4.0% | 1.94B YoY+100.1% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 218B YoY+11.1% | 196B YoY+2.7% | 191B YoY-0.2% | 191B YoY-23.1% | 249B YoY+28.2% | |
| P/E | 33.4× YoY+128.1% | 14.6× YoY-60.5% | 37.0× YoY+52.6% | 24.3× YoY-31.1% | 35.2× YoY-18.5% | |
| P/S | 4.9× YoY+5.1% | 4.7× YoY-2.2% | 4.8× YoY+12.5% | 4.3× YoY-26.4% | 5.8× YoY+3.0% | |
| P/B | 4.2× YoY+1.5% | 4.1× YoY-19.3% | 5.1× YoY-5.0% | 5.4× YoY-22.8% | 7.0× YoY+17.4% | |
| P/FCF | 29.5× YoY-4.6% | 30.9× YoY-27.4% | 42.5× YoY+89.8% | 22.4× YoY-22.1% | 28.8× YoY-15.1% | |
| Earnings yield | 3.0% YoY-56.2% | 6.8% YoY+152.9% | 2.7% YoY-34.5% | 4.1% YoY+45.0% | 2.8% YoY+22.7% | |
| FCF yield | 3.4% YoY+4.9% | 3.2% YoY+37.7% | 2.4% YoY-47.3% | 4.5% YoY+28.4% | 3.5% YoY+17.8% | |
| Dividend yield | 1.9% YoY-3.3% | 2.0% YoY+4.8% | 1.9% YoY+8.1% | 1.7% | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ABT's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ABT filings on SEC EDGAR → Not investment advice.